drugset / Trial / NCT00475696
Urge Incontinence Bladder Overactivity Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Examine the efficacy and safety of duloxetine in subjects with symptoms of bladder overactivity due to pure detrusor instability or sensory urgency. Subjects in study will be permitted to escalate or de-escalate between 80 mg/day and 120 mg/day in consultation with the investigator and based on their adverse events.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 80 mg | — |
| Subject | Duloxetine | Small molecule | 120 mg | — |
Indications
No indication recorded.